Paxman AB (publ) PAX
Updated: 11 Jun 2026
No signal published yet
We already track Paxman and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow Paxman AB (publ)? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Paxman free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
On May 21, 2026, Paxman reported a 33.5% revenue growth for the first quarter, driven by strong performance in the U.S. market. At the Annual General Meeting on May 22, 2026, Mats Hyttinge was elected as a new board member and a new employee incentive program was approved. The company is also preparing for the launch of a new system to prevent chemotherapy-induced peripheral neuropathy.
What Firelda Watch includes for Paxman AB (publ)
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow Paxman AB (publ)? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Paxman free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more